Zali et al., 2003 - Google Patents
SEROPREVALENCE OF CELIAC DISEASE IN AUTOIMMUNE HEPATITIS AND CHRONIC HEPATITIS B: 254Zali et al., 2003
- Document ID
- 5191737221445081852
- Author
- Zali M
- Sima H
- Hekmatdoost A
- Ghaziani T
- Mashayekh A
- Publication year
- Publication venue
- Official journal of the American College of Gastroenterology| ACG
External Links
Snippet
Purpose: Strip-based tests for determining anti-HCV antibody are ideal for confirming the results obtained in the 3rd generation ELISA. The present study aims at evaluating an indigenously developed Strip Immunoblot Assay (SIBA), HCV Blot (J. Mitra co., Ltd, New …
- 206010009839 Coeliac disease 0 title description 6
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
- G01N33/5767—Immunoassay; Biospecific binding assay for hepatitis non-A, non-B hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/576—Immunoassay; Biospecific binding assay for hepatitis
- G01N33/5761—Hepatitis B
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Berasain et al. | Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology | |
| Lin et al. | Diagnostic value of immunoglobulin G (IgG) and IgM anti-hepatitis E virus (HEV) tests based on HEV RNA in an area where hepatitis E is not endemic | |
| Yuki et al. | Long‐term histologic and virologic outcomes of acute self‐limited hepatitis B | |
| Esteban et al. | High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus | |
| Park et al. | Seroprevalence of anti-hepatitis E virus (HEV) in a Korean population: comparison of two commercial anti-HEV assays | |
| Kim et al. | Prevalence of occult HBV infection among subjects with normal serum ALT levels in Korea | |
| Knöll et al. | Serological pattern “anti-HBc alone”: characterization of 552 individuals and clinical significance | |
| Chen et al. | A study on sequence variations in pre‐S/surface, X and enhancer II/core promoter/precore regions of occult hepatitis B virus in non‐B, non‐C hepatocellular carcinoma patients in Taiwan | |
| Mojiri et al. | Hepatitis B virus genotypes in southwest Iran: molecular, serological and clinical outcomes | |
| Ismail et al. | Occult hepatitis B virus infection in Egyptian hemodialysis patients with or without hepatitis C virus infection | |
| Honarkar et al. | Occult hepatitis B among chronic liver disease patients | |
| Makvandi et al. | Occult hepatitis B virus among the patients with abnormal alanine transaminase | |
| US8765386B2 (en) | Oral fluid rapid assay for hepatitis C virus (HCV) antibodies using non-antibody labeling of IgA molecules recognizing HCV peptide epitopes | |
| Franzè et al. | Occult hepatitis B virus infection in hepatitis C virus negative chronic liver diseases | |
| Nabi et al. | Hepatitis C as a cause of chronic liver disease in northern Pakistan | |
| Zali et al. | SEROPREVALENCE OF CELIAC DISEASE IN AUTOIMMUNE HEPATITIS AND CHRONIC HEPATITIS B: 254 | |
| Khaja et al. | ASSESSMENT OF ANTIGENIC SENSITIVITY OF RECOMBINANT HCV PROTEINS BY INDIGENEOUS STRIP IMMUNOBLOT ASSAY (SIBA) HCV BLOT FOR THE DETECTION OF HEPATITIS C VIRUS INFECTION: 253 | |
| Duermeyer et al. | An enzyme‐linked immunosorbent assay for an antigen related to non‐a, non‐b hepatitis and its antibody: Partial characterization of the antigen and chimpanzee transmission | |
| Mohraz et al. | Molecular analysis of occult hepatitis B infection among Iranian HIV-positive patients | |
| Tassopoulos et al. | Clinicopathological features and natural history of acute sporadic non‐(A‐E) hepatitis | |
| Shiha et al. | Immunohistochemical identification of HCV target antigen in paraffin‐embedded liver tissue: reproducibility and staining patterns | |
| Esmat et al. | Occult Hepatitis b virus infection among Egyptian hepatitis c virus seropositive and seronegative hemodialysis patients in Sohag government, upper Egypt | |
| Kikuchi et al. | DOES HEPATITIS E INFECTION EFFECT THE HISTOPATHOLOGICAL PROGRESSION FOR PATIENTS WITH HEPATITIS C?: 252 | |
| Lin et al. | Seroprevalence of hepatitis C virus infection and its association with natural infection of hepatitis B virus among preschool children in Taiwan | |
| Laskus et al. | Hepatitis C virus antibody in Poland |